Studies into the relationship between diabetes and amyotrophic lateral sclerosis (ALS) have produced conflicting results. In young patients, diabetes is a consistent risk factor for ALS; in older patients, diabetes protects against ALS in Europe, but increases the risk of ALS in Asia. Environment and genotype might both contribute to this variation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The links between diabetes mellitus and amyotrophic lateral sclerosis
Neurological Sciences Open Access 05 February 2021
-
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Molecular Neurodegeneration Open Access 04 December 2018
-
Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival
Molecular Neurodegeneration Open Access 21 September 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dupuis, L., Pradat, P. F., Ludolph, A. C. & Loeffler, J. P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 10, 75–82 (2011).
Kioumourtzoglou, M. A. et al. Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study. JAMA Neurol. http://dx.doi.org/10.1001/jamaneurol.2015.0910.
Mariosa, D., Kamel, F., Bellocco, R., Ye, W. & Fang, F. Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur. J. Neurol. http://dx.doi.org/10.1111/ene.12632.
Sun, Y. et al. Risk of amyotrophic lateral sclerosis in patients with diabetes: a nationwide population-based cohort study. J. Epidemiol. 25, 445–451 (2015).
Turner, M. R., Goldacre, R., Ramagopalan, S., Talbot, K. & Goldacre, M. J. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 81, 1222–1225 (2013).
Zaldivar, T. et al. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 72, 1640–1645 (2009).
Ogaki, K. et al. Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol. Aging 33, 2527.e11–2527.e16 (2012).
Palamiuc, L. et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 7, 526–546 (2015).
Stallings, N. R. et al. TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS ONE 8, e71793 (2013).
Logroscino, G. & Ludolph, A. Amyotrophic lateral sclerosis: new ideas from cancer. Lancet Neurol. 13, 1067–1068 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Logroscino, G. Are diabetes and amyotrophic lateral sclerosis related?. Nat Rev Neurol 11, 488–490 (2015). https://doi.org/10.1038/nrneurol.2015.145
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2015.145
This article is cited by
-
The links between diabetes mellitus and amyotrophic lateral sclerosis
Neurological Sciences (2021)
-
Shared Pathological Mechanisms Between Diabetes Mellitus and Neurodegenerative Diseases
Current Pharmacology Reports (2019)
-
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Molecular Neurodegeneration (2018)
-
Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival
Molecular Neurodegeneration (2017)